NCAM1 and neoplasm: Results showed that the DC-stimulated CIK cells contained more population of CD3+CD56+ subset (14–36%), which are characterized to display higher cell proliferation rates and more potent cytotoxicity against tumor cells [24], as compared to PBL-derived lymphocytes without cytokine stimulation (4.02%).